Aushon Biosystems Inc, based in Burlington, MA, is a leading provider of ultrasensitive biomarker detection solutions for various therapeutic areas including neurology, oncology, immunology, inflammation, infectious disease, and cardiology. Their Simoa precision instruments, wide-ranging menu of assay kits, and custom assay development services empower researchers to make new discoveries in disease and treatment, revolutionizing the future of healthcare.
With their Simoa technology, Aushon Biosystems enables researchers to measure biomarkers at lower levels than ever before, allowing for earlier disease detection, improved prognoses, and enhanced treatment methods. Their commitment to precision science is evident through numerous peer-reviewed publications showcasing the impact of Simoa technology in oncology, neurology, cardiology, inflammation, and infectious disease research. Aushon Biosystems is dedicated to advancing the biology of health and disease through their innovative solutions.
Generated from the website